RBC Capital analyst Gregory Renza maintained a Buy rating on Verastem (VSTM – Research Report) today and set a price target of $13.00.

RBC Capital analyst Gregory Renza maintained a Buy rating on Nuvation Bio (NUVB – Research Report) today and set a price target of $6.00.

Lori Calvasina, head of US equity strategy at RBC Capital Markets, discusses what a red sweep in the US election could mean ...

Find insight on Fannie Mae, Swiss Re, National Australia Bank and more in the latest Market Talks covering financial services ...

Gold and silver futures fell Wednesday as traders anxious about the election pulled out of the safe-haven assets. Prices for ...

The revelations mean HSBC is the fourth bank to have hosted a private briefing with RBA officials that breached confidentiality requirements.

The Bank of England has decided to reduce the Base Rate for the second time this year, with a majority vote of 8-1. With inflation resting below the Bank’s Government-set target at 1.7% in the 12 ...

Shares of Wizz Air Holdings Plc (LON: WIZZ) were down over 3% on Thursday following its half-year results, which posted a net profit decline of 21.3% to €315 mi ...

The election of Donald Trump as U.S. president is a net positive result for the aerospace and defense sector, RBC Capital Markets Ken Herbert said. U.S. defense spending and support for U.S. defense ...

“LYFT is no longer a ride-hailing pure-play with it now embarking on partnerships in food delivery and AVs,” said RBC Capital Markets analyst and Lyft bull Brad Erikson. Lyft recently unveiled a ...

Domestic stocks outperformed the S&P 500 by a significant margin during the third quarter and BMO chief investment officer ...

Gilead Sciences reported third-quarter financial results that handily beat Wall Street expectations on Wednesday as sales ...